Good sign imo exercising this warrant so early - gives the company another almost $1 million..
Mayo has had some very successful healthcare investments in the past with large gains like EXAS and NVRO.
10 yr collaboration working on Cardiac, Neurology, etc....
This adds to their largest cash balance in history - good for the next yr at least into commercialization later this yr.
Remember from last months press release:
“BioSig has more cash on its balance sheet today than any other time in our 10 year corporate history, which should be sufficient to finance our operations for at least 12 months.”